hacksnanax.blogg.se

Medacta nextar
Medacta nextar






medacta nextar medacta nextar

NextAR Shoulder: Real-Time Guidance in Shoulder Arthroplasty With a precise reconstruction of patient bone morphology, the NextAR Knee application allows direct tracking of the collateral ligaments and a 3D analysis of soft tissue behavior throughout the whole range of motion during surgery, bringing patient-specific ligament balancing to the next level. NextAR Knee, the first FDA-cleared Augmented Reality surgical platform for total knee replacement, is now CE-marked. NextAR Knee: Intraoperative Personalized Precision and Optimized Balance in Total Knee Replacement Together with a comprehensive implant portfolio and surgical techniques, MySolutions empowers Medacta’s holistic approach to personalized medicine aiming at bringing value at every step throughout the entire patient journey: preoperative, intraoperative, and postoperative. NextAR is part of the MySolutions ecosystem, which enhances Medacta’s personalized medicine offering. Indeed, a single hardware will apply to diverse software, with economic benefits for the healthcare systems. NextAR is the first platform to offer Augmented Reality solutions for both spine and joint replacement procedures. With a low upfront capital investment and overall low cost per case compared to other technologies, this translates into greater efficiency in the operating room, which is particularly relevant for US Ambulatory Surgery Centers (ASCs). Its smart delivery tools may improve efficiency in computer-assisted surgery by offering a compact solution that avoids the need for a bulky external detection platform. – NextAR Augmented Reality Smart Glasses, that allow for the visualization of surgical actions superimposed onto the operative field.

medacta nextar

– NextAR TS, Medacta’s proprietary tracking system, a compact, single-use and ready-to-use solution NextAR is Medacta’s proprietary AR platform that makes image-based planning and analysis efficient and precise, offering smart delivery tools for an accurate and personalized surgery. NextAR perfectly fits in Medacta’s vision and in our sophisticated MySolutions personalized ecosystem, focused on delivering advanced personalized solutions that support the surgeon’s care of each patient.’ We are proud to have developed an extremely versatile platform, with a single, compact hardware that applies to both joint and spine applications. Efficiency in the operating room is crucial for surgeons and hospitals, and NextAR has the potential to provide significant benefits to healthcare systems around the world. Also, Medacta’s NextAR Shoulder Application has received clearance from the US Food and Drug Administration (FDA), further expanding the US NextAR offering, which already includes the Knee Application, FDA-cleared in 2020.įrancesco Siccardi, CEO of Medacta says: ‘With our NextAR Platform we wanted to take another step forward in personalized medicine, improving accuracy in computer-assisted surgery. “Requiring a very limited investment in capital equipment, the NextAR platform perfectly represents Medacta’s commitment to develop solutions that are able to improve patient outcomes and health care system sustainability,” he said.Medacta Group SA today announced it has received CE marking for the NextAR TM Knee (NextAR TKA), Shoulder and Spine Applications as part of its NextAR Augmented Reality (AR) Surgical Platform. “Patients and surgeons are attracted by improved outcomes and innovation, the NextAR platform is one Medacta answer to the current race in orthopedic technology and I am very excited about this milestone achievement, Francesco Siccardi, CEO of Medacta, said in the release. The platform, engineered with artificial intelligence and machine learning, is the first FDA-cleared augmented reality technology to enhance visualization during real-time TKA procedures. Medacta Group SA has received FDA clearance for its NextAR augmented reality-based platform technology, which is designed for total knee arthroplasty, according to a press release. If you continue to have this issue please contact to Healio








Medacta nextar